Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P00813 100 ADA ADA1 Immunodeficiency Acetylation N K9 P00813 100 ADA ADA1 Kidney renal papillary cell carcinoma Acetylation N K9 P00813 100 ADA ADA1 Lung squamous cell carcinoma Acetylation N K9 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K9 P00813 100 ADA ADA1 Kidney renal papillary cell carcinoma Ubiquitination N K9 P00813 100 ADA ADA1 Lung squamous cell carcinoma Ubiquitination N K9 P00813 100 ADA ADA1 Severe combined immunodeficiency Ubiquitination N K23 P00813 100 ADA ADA1 Colon adenocarcinoma Phosphorylation N Y29 P00813 100 ADA ADA1 Immunodeficiency Phosphorylation N Y29 P00813 100 ADA ADA1 Prostate adenocarcinoma Phosphorylation N Y29 P00813 100 ADA ADA1 Colon adenocarcinoma Acetylation N K54 P00813 100 ADA ADA1 Immunodeficiency Acetylation N K54 P00813 100 ADA ADA1 Skin cutaneous melanoma Acetylation N K54 P00813 100 ADA ADA1 Colon adenocarcinoma Ubiquitination N K54 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K54 P00813 100 ADA ADA1 Skin cutaneous melanoma Ubiquitination N K54 P00813 100 ADA ADA1 Immunodeficiency Phosphorylation N Y67 P00813 100 ADA ADA1 Uterine corpus endometrial carcinoma Phosphorylation N Y67 P00813 100 ADA ADA1 Severe combined immunodeficiency Phosphorylation N Y84 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K90 P00813 100 ADA ADA1 Uterine corpus endometrial carcinoma Ubiquitination N K90 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K92 P00813 100 ADA ADA1 Severe combined immunodeficiency Ubiquitination N K92 P00813 100 ADA ADA1 Bladder urothelial carcinoma Ubiquitination N K111 P00813 100 ADA ADA1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K111 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K111 P00813 100 ADA ADA1 Severe combined immunodeficiency Ubiquitination N K111 P00813 100 ADA ADA1 Stomach adenocarcinoma Ubiquitination N K111 P00813 100 ADA ADA1 Colon adenocarcinoma Ubiquitination N K147 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K147 P00813 100 ADA ADA1 Pancreatic cancer Ubiquitination N K147 P00813 100 ADA ADA1 Pancreatic ductal adenocarcinoma Ubiquitination N K147 P00813 100 ADA ADA1 Severe combined immunodeficiency Ubiquitination N K147 P00813 100 ADA ADA1 Immunodeficiency Phosphorylation N S162 P00813 100 ADA ADA1 Immunodeficiency Acetylation N K164 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K164 P00813 100 ADA ADA1 Immunodeficiency Acetylation N K170 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K170 P00813 100 ADA ADA1 Head and neck squamous cell carcinoma Ubiquitination N K171 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K171 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K206 P00813 100 ADA ADA1 Severe combined immunodeficiency Ubiquitination N K206 P00813 100 ADA ADA1 Severe combined immunodeficiency Phosphorylation N S220 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K225 P00813 100 ADA ADA1 Lung adenocarcinoma Ubiquitination N K225 P00813 100 ADA ADA1 Skin cutaneous melanoma Ubiquitination N K225 P00813 100 ADA ADA1 Stomach adenocarcinoma Ubiquitination N K225 P00813 100 ADA ADA1 Immunodeficiency Acetylation N K232 P00813 100 ADA ADA1 Stomach adenocarcinoma Acetylation N K232 P00813 100 ADA ADA1 Stomach cancer Acetylation N K232 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K232 P00813 100 ADA ADA1 Stomach adenocarcinoma Ubiquitination N K232 P00813 100 ADA ADA1 Head and neck squamous cell carcinoma Ubiquitination N K273 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K273 P00813 100 ADA ADA1 Severe combined immunodeficiency Ubiquitination N K273 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K284 P00813 100 ADA ADA1 Severe combined immunodeficiency Phosphorylation N Y290 P00813 100 ADA ADA1 Severe combined immunodeficiency Phosphorylation N S291 P00813 100 ADA ADA1 Esophageal adenocarcinoma Ubiquitination N K301 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K301 P00813 100 ADA ADA1 Severe combined immunodeficiency Ubiquitination N K301 P00813 100 ADA ADA1 Severe combined immunodeficiency Phosphorylation N Y308 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K312 P00813 100 ADA ADA1 Stomach adenocarcinoma Ubiquitination N K312 P00813 100 ADA ADA1 Lung adenocarcinoma Acetylation N K323 P00813 100 ADA ADA1 Lung adenocarcinoma Ubiquitination N K323 P00813 100 ADA ADA1 Severe combined immunodeficiency Ubiquitination N K331 P00813 100 ADA ADA1 Stomach adenocarcinoma Ubiquitination N K331 P00813 100 ADA ADA1 Bladder urothelial carcinoma Ubiquitination N K340 P00813 100 ADA ADA1 Immunodeficiency Ubiquitination N K340 P00813 100 ADA ADA1 Stomach adenocarcinoma Ubiquitination N K340 P00813 100 ADA ADA1 Immunodeficiency Phosphorylation N Y348 P00813 100 ADA ADA1 Stomach adenocarcinoma Phosphorylation N Y348 P31785 3561 IL2RG Breast invasive carcinoma N-linked glycosylation N N84 P31785 3561 IL2RG Hepatocellular carcinoma N-linked glycosylation N N84 P31785 3561 IL2RG Severe combined immunodeficiency Ubiquitination N K101 P31785 3561 IL2RG Bladder urothelial carcinoma Ubiquitination N K119 P31785 3561 IL2RG Severe combined immunodeficiency Ubiquitination N K119 P31785 3561 IL2RG Severe combined immunodeficiency Ubiquitination N K147 P31785 3561 IL2RG Severe combined immunodeficiency Phosphorylation N T161 P31785 3561 IL2RG Severe combined immunodeficiency Ubiquitination N K164 P31785 3561 IL2RG Bladder urothelial carcinoma Ubiquitination N K217 P31785 3561 IL2RG Colon adenocarcinoma Ubiquitination N K217 P31785 3561 IL2RG Pancreatic cancer Ubiquitination N K217 P31785 3561 IL2RG Uterine corpus endometrial carcinoma Ubiquitination N K217 P31785 3561 IL2RG X-linked combined immunodeficiency Ubiquitination N K217 P31785 3561 IL2RG Kidney renal clear cell carcinoma Phosphorylation N T292 P31785 3561 IL2RG Uterine corpus endometrial carcinoma Phosphorylation N T292 P31785 3561 IL2RG X-linked combined immunodeficiency Phosphorylation N T292 P31785 3561 IL2RG X-linked combined immunodeficiency Ubiquitination N K294 P31785 3561 IL2RG Bladder urothelial carcinoma Phosphorylation N S320 P31785 3561 IL2RG Transitional cell carcinoma Phosphorylation N S320 P31785 3561 IL2RG Bladder urothelial carcinoma Phosphorylation N Y325 P31785 3561 IL2RG Transitional cell carcinoma Phosphorylation N Y325 P31785 3561 IL2RG Thyroid carcinoma Phosphorylation N Y357 P31785 3561 IL2RG Thyroid carcinoma Phosphorylation N Y363 P52333 3718 JAK3 Immunodeficiency Phosphorylation N S5 P52333 3718 JAK3 Colon adenocarcinoma Phosphorylation N T8 P52333 3718 JAK3 Immunodeficiency Phosphorylation N T8 P52333 3718 JAK3 Uterine corpus endometrial carcinoma Phosphorylation N T8 P52333 3718 JAK3 Colon adenocarcinoma Phosphorylation N S15 P52333 3718 JAK3 Immunodeficiency Phosphorylation N S15 P52333 3718 JAK3 Uterine corpus endometrial carcinoma Phosphorylation N S15 P52333 3718 JAK3 Colon adenocarcinoma Phosphorylation N S17 P52333 3718 JAK3 Immunodeficiency Phosphorylation N S17 P52333 3718 JAK3 Uterine corpus endometrial carcinoma Phosphorylation N S17 P52333 3718 JAK3 Colon adenocarcinoma Phosphorylation N S20 P52333 3718 JAK3 Immunodeficiency Phosphorylation N S20 P52333 3718 JAK3 Uterine corpus endometrial carcinoma Phosphorylation N S20 P52333 3718 JAK3 Severe combined immunodeficiency Phosphorylation N Y105 P52333 3718 JAK3 Lung cancer Ubiquitination N K122 P52333 3718 JAK3 Bladder urothelial carcinoma Ubiquitination N K186 P52333 3718 JAK3 Transitional cell carcinoma Ubiquitination N K186 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K361 P52333 3718 JAK3 Head and neck squamous cell carcinoma Ubiquitination N K388 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K388 P52333 3718 JAK3 Renal cell carcinoma Ubiquitination N K388 P52333 3718 JAK3 Stomach adenocarcinoma Ubiquitination N K388 P52333 3718 JAK3 Head and neck squamous cell carcinoma Ubiquitination N K390 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K390 P52333 3718 JAK3 Renal cell carcinoma Ubiquitination N K390 P52333 3718 JAK3 Stomach adenocarcinoma Ubiquitination N K390 P52333 3718 JAK3 Breast invasive carcinoma Ubiquitination N K482 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K482 P52333 3718 JAK3 Severe combined immunodeficiency Ubiquitination N K482 P52333 3718 JAK3 Lung cancer Phosphorylation N S498 P52333 3718 JAK3 Breast invasive carcinoma Ubiquitination N K534 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K534 P52333 3718 JAK3 Adrenocortical carcinoma Ubiquitination N K652 P52333 3718 JAK3 Breast invasive carcinoma Ubiquitination N K652 P52333 3718 JAK3 Hepatocellular carcinoma Ubiquitination N K652 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K652 P52333 3718 JAK3 Bladder urothelial carcinoma Phosphorylation N S663 P52333 3718 JAK3 Breast invasive carcinoma Phosphorylation N S663 P52333 3718 JAK3 Immunodeficiency Phosphorylation N S663 P52333 3718 JAK3 Breast invasive carcinoma Ubiquitination N K734 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K734 P52333 3718 JAK3 Severe combined immunodeficiency Phosphorylation N Y762 P52333 3718 JAK3 Immunodeficiency Phosphorylation N Y785 P52333 3718 JAK3 Lung adenocarcinoma Phosphorylation N Y785 P52333 3718 JAK3 Hepatocellular carcinoma Ubiquitination N K823 P52333 3718 JAK3 Hepatocellular carcinoma Ubiquitination N K830 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K830 P52333 3718 JAK3 Renal cell carcinoma Ubiquitination N K830 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K855 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K876 P52333 3718 JAK3 Uterine carcinosarcoma Ubiquitination N K876 P52333 3718 JAK3 Immunodeficiency Phosphorylation N S880 P52333 3718 JAK3 Glioblastoma multiforme Phosphorylation N Y886 P52333 3718 JAK3 Immunodeficiency Phosphorylation N Y886 P52333 3718 JAK3 Blastoma Phosphorylation N Y904 P52333 3718 JAK3 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N Y904 P52333 3718 JAK3 Immunodeficiency Phosphorylation N Y904 P52333 3718 JAK3 Liver cancer Phosphorylation N Y904 P52333 3718 JAK3 Immunodeficiency Phosphorylation N Y929 P52333 3718 JAK3 Immunodeficiency Phosphorylation N S931 P52333 3718 JAK3 Head and neck squamous cell carcinoma Ubiquitination N K972 P52333 3718 JAK3 Lung adenocarcinoma Ubiquitination N K972 P52333 3718 JAK3 Hepatocellular carcinoma Phosphorylation N Y980 P52333 3718 JAK3 Uterine corpus endometrial carcinoma Phosphorylation N Y980 P52333 3718 JAK3 Hepatocellular carcinoma Phosphorylation N Y981 P52333 3718 JAK3 Uterine corpus endometrial carcinoma Phosphorylation N Y981 P52333 3718 JAK3 Bladder urothelial carcinoma Ubiquitination N K1117 P52333 3718 JAK3 Immunodeficiency Ubiquitination N K1117 P52333 3718 JAK3 Bladder urothelial carcinoma Phosphorylation N S1120 P52333 3718 JAK3 Immunodeficiency Phosphorylation N S1120 Q9H9Q4 79840 NHEJ1 XLF Severe combined immunodeficiency Phosphorylation N S55 Q9H9Q4 79840 NHEJ1 XLF Brain lower grade glioma Ubiquitination N K180 Q9H9Q4 79840 NHEJ1 XLF Colon adenocarcinoma Ubiquitination N K180 Q9H9Q4 79840 NHEJ1 XLF Lung adenocarcinoma Phosphorylation C S203 Q9H9Q4 79840 NHEJ1 XLF Colon adenocarcinoma Phosphorylation N T223 Q9H9Q4 79840 NHEJ1 XLF Skin cutaneous melanoma Phosphorylation N T223 Q9H9Q4 79840 NHEJ1 XLF Kidney renal clear cell carcinoma Phosphorylation N S263 Q9H9Q4 79840 NHEJ1 XLF Kidney renal clear cell carcinoma Phosphorylation N T266 Q9H9Q4 79840 NHEJ1 XLF Skin cutaneous melanoma Phosphorylation N S287 Q9H9Q4 79840 NHEJ1 XLF Skin cutaneous melanoma Methylation N K288 P52333 3718 JAK3 Extranodal nasal-type natural killer cell lymphoma NKCL cell line Tyrosine phosphorylation U Y980 23689514 P31785 3561 IL2RG Immunodeficiency Glycosylation C Y125 15924140